Warnings on venous thromboembolism risks may have been premature. New data may lead to change in use of third-generation OCs.
D001695:Biology; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D017135:Desogestrel; D019049:Developed Countries; D004194:Disease; D004617:Embolism; D004739:England; D005060:Europe; D005193:Family Planning Services; D006262:Health; D011634:Public Health; D012307:Risk Factors; D012449:Safety; D013923:Thromboembolism; D006113:United Kingdom; D014652:Vascular Diseases
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D017135:Desogestrel
Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Desogestrel; Developed Countries; Diseases; Embolism; England; Europe; Family Planning; Gestodene; Health; Northern Europe; Oral Contraceptives; Public Health; Risk Factors; Safety; Thromboembolism; United Kingdom; Vascular Diseases